{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:37:20Z","timestamp":1789706240495,"version":"4.0.1"},"reference-count":105,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008018","name":"Victorian Cancer Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001043","name":"CASS Foundation Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001043","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005190","name":"Melanoma Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Cell"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.molcel.2026.06.003","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:27:45Z","timestamp":1783006065000},"page":"2521-2538.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cytosolic EZH2-IMPDH2 complexes regulate melanoma progression and metastasis via GTP"],"prefix":"10.1016","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4590-0577","authenticated-orcid":false,"given":"Gamze","family":"Kuser-Abali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihito","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peinan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pacman","family":"Szeto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher K.","family":"Barlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Pomilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Boudes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar Masoumi","family":"Moghaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isobel","family":"Leece","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen G.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malaka","family":"Ameratunga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas C.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles C.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf B.","family":"Schittenhelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Naranbhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Davidovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7673-4655","authenticated-orcid":false,"given":"Mark","family":"Shackleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molcel.2026.06.003_bib1","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1101\/gad.189365.112","article-title":"Links between metabolism and cancer","volume":"26","author":"Dang","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.molcel.2026.06.003_bib2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.celrep.2013.09.015","article-title":"A purine nucleotide biosynthesis enzyme guanosine monophosphate reductase is a suppressor of melanoma invasion","volume":"5","author":"Wawrzyniak","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.molcel.2026.06.003_bib3","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.cell.2008.09.043","article-title":"Rac activation and inactivation control plasticity of tumor cell movement","volume":"135","author":"Sanz-Moreno","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.molcel.2026.06.003_bib4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ccr.2011.06.018","article-title":"ROCK and JAK1 signaling cooperate to control actomyosin contractility in tumor cells and stroma","volume":"20","author":"Sanz-Moreno","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molcel.2026.06.003_bib5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nrc1015","article-title":"Does the ribosome translate cancer?","volume":"3","author":"Ruggero","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.molcel.2026.06.003_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2003477","article-title":"Revisiting the nucleolus: from marker to dynamic integrator of cancer signaling","volume":"5","author":"Ruggero","year":"2012","journal-title":"Sci. Signal."},{"key":"10.1016\/j.molcel.2026.06.003_bib7","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/s41556-019-0363-9","article-title":"IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastoma","volume":"21","author":"Kofuji","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molcel.2026.06.003_bib8","doi-asserted-by":"crossref","DOI":"10.1186\/s13000-017-0675-7","article-title":"Nucleoli cytomorphology in cutaneous melanoma cells - a new prognostic approach to an old concept","volume":"12","author":"Donizy","year":"2017","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.molcel.2026.06.003_bib9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/jb\/mvaa085","article-title":"GTP metabolic reprogramming by IMPDH2: unlocking cancer cells' fuelling mechanism","volume":"168","author":"Kofuji","year":"2020","journal-title":"J. Biochem."},{"key":"10.1016\/j.molcel.2026.06.003_bib10","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1242\/jcs.01660","article-title":"The Ras superfamily at a glance","volume":"118","author":"Wennerberg","year":"2005","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.molcel.2026.06.003_bib11","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.4161\/cc.10.17.17068","article-title":"Characterization of human melanoma cell lines and melanocytes by proteome analysis","volume":"10","author":"Caputo","year":"2011","journal-title":"Cell Cycle (Georget. Tex.)"},{"key":"10.1016\/j.molcel.2026.06.003_bib12","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.4161\/cc.6390","article-title":"Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cells","volume":"7","author":"Mannava","year":"2008","journal-title":"Cell Cycle (Georget. Tex.)"},{"key":"10.1016\/j.molcel.2026.06.003_bib13","first-page":"259","article-title":"Induction of cell differentiation in melanoma cells by inhibitors of IMP dehydrogenase: altered patterns of IMP dehydrogenase expression and activity","volume":"1","author":"Kiguchi","year":"1990","journal-title":"Cell Growth Differ."},{"key":"10.1016\/j.molcel.2026.06.003_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-53877-z","article-title":"Nuclear IMPDH2 controls the DNA damage response by modulating PARP1 activity","volume":"15","author":"Espinar","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molcel.2026.06.003_bib15","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1021\/cr900021w","article-title":"IMP dehydrogenase: structure, mechanism, and inhibition","volume":"109","author":"Hedstrom","year":"2009","journal-title":"Chem. Rev."},{"key":"10.1016\/j.molcel.2026.06.003_bib16","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1021\/bi982858v","article-title":"Characteristics and crystal structure of bacterial inosine-5\u2032-monophosphate dehydrogenase","volume":"38","author":"Zhang","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.molcel.2026.06.003_bib17","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.53243","article-title":"Cryo-EM structures demonstrate human IMPDH2 filament assembly tunes allosteric regulation","volume":"9","author":"Johnson","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.molcel.2026.06.003_bib18","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0092-8674(00)81275-1","article-title":"Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid","volume":"85","author":"Sintchak","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.molcel.2026.06.003_bib19","doi-asserted-by":"crossref","first-page":"E5986","DOI":"10.1073\/pnas.1706778114","article-title":"Highly selective inhibition of IMPDH2 provides the basis of antineuroinflammation therapy","volume":"114","author":"Liao","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.molcel.2026.06.003_bib20","article-title":"Wnt\/beta-catenin signalling activates IMPDH2-mediated purine metabolism to facilitate oxaliplatin resistance by inhibiting caspase-dependent apoptosis in colorectal cancer","volume":"22","author":"Huang","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.molcel.2026.06.003_bib21","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.1076997","article-title":"Role of histone H3 lysine 27 methylation in Polycomb-group silencing","volume":"298","author":"Cao","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.molcel.2026.06.003_bib22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molcel.2004.06.020","article-title":"SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex","volume":"15","author":"Cao","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molcel.2026.06.003_bib23","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nrm2763","article-title":"Mechanisms of polycomb gene silencing: knowns and unknowns","volume":"10","author":"Simon","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.molcel.2026.06.003_bib24","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1158\/0008-5472.CAN-20-2147","article-title":"EZH2-Targeted Therapies in Cancer: Hype or a Reality","volume":"80","author":"Eich","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.molcel.2026.06.003_bib25","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1200\/JCO.2005.01.5180","article-title":"EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast","volume":"24","author":"Bachmann","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.molcel.2026.06.003_bib26","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1093\/emboj\/cdg542","article-title":"EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer","volume":"22","author":"Bracken","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.molcel.2026.06.003_bib27","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1158\/1541-7786.MCR-10-0511","article-title":"EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21\/CDKN1A expression","volume":"9","author":"Fan","year":"2011","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.molcel.2026.06.003_bib28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ccell.2018.06.001","article-title":"EZH2-Mediated Primary Cilium Deconstruction Drives Metastatic Melanoma Formation","volume":"34","author":"Zingg","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molcel.2026.06.003_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7051","article-title":"The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors","volume":"6","author":"Zingg","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molcel.2026.06.003_bib30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neo.2016.01.003","article-title":"Somatic Copy Number Amplification and Hyperactivating Somatic Mutations of EZH2 Correlate With DNA Methylation and Drive Epigenetic Silencing of Genes Involved in Tumor Suppression and Immune Responses in Melanoma","volume":"18","author":"Tiffen","year":"2016","journal-title":"Neoplasia"},{"key":"10.1016\/j.molcel.2026.06.003_bib31","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.celrep.2017.07.007","article-title":"The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy","volume":"20","author":"Zingg","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.molcel.2026.06.003_bib32","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm.4036","article-title":"Targeting EZH2 in cancer","volume":"22","author":"Kim","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.molcel.2026.06.003_bib33","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1007\/s12325-020-01379-x","article-title":"The Promise for Histone Methyltransferase Inhibitors for Epigenetic Therapy in Clinical Oncology: A Narrative Review","volume":"37","author":"Rugo","year":"2020","journal-title":"Adv. Ther."},{"key":"10.1016\/j.molcel.2026.06.003_bib34","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-020-00937-8","article-title":"EZH2: a novel target for cancer treatment","volume":"13","author":"Duan","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.molcel.2026.06.003_bib35","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S1470-2045(20)30451-4","article-title":"Tazemetostat in advanced epithelioid sarcoma with loss of INI1\/SMARCB1: an international, open-label, phase 2 basket study","volume":"21","author":"Gounder","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.molcel.2026.06.003_bib36","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S1470-2045(20)30441-1","article-title":"Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial","volume":"21","author":"Morschhauser","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.molcel.2026.06.003_bib37","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ni.3125","article-title":"The methyltransferase Ezh2 controls cell adhesion and migration through direct methylation of the extranuclear regulatory protein talin","volume":"16","author":"Gunawan","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molcel.2026.06.003_bib38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1101\/gad.173930.111","article-title":"PRC2 directly methylates GATA4 and represses its transcriptional activity","volume":"26","author":"He","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.molcel.2026.06.003_bib39","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1111\/cas.14840","article-title":"The noncanonical role of EZH2 in cancer","volume":"112","author":"Huang","year":"2021","journal-title":"Cancer Sci."},{"key":"10.1016\/j.molcel.2026.06.003_bib40","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ccr.2013.04.008","article-title":"Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells","volume":"23","author":"Kim","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molcel.2026.06.003_bib41","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1016\/j.celrep.2018.11.035","article-title":"Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator","volume":"25","author":"Kim","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.molcel.2026.06.003_bib42","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1038\/s41388-020-1332-2","article-title":"EZH2 has a non-catalytic and PRC2-independent role in stabilizing DDB2 to promote nucleotide excision repair","volume":"39","author":"Koyen","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.molcel.2026.06.003_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1233953","article-title":"Non-canonical functions of EZH2 in cancer","volume":"13","author":"Zimmerman","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.molcel.2026.06.003_bib44","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.cell.2005.02.029","article-title":"Polycomb group protein ezh2 controls actin polymerization and cell signaling","volume":"121","author":"Su","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.molcel.2026.06.003_bib45","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/pros.20705","article-title":"The Polycomb Group protein EZH2 regulates actin polymerization in human prostate cancer cells","volume":"68","author":"Bryant","year":"2008","journal-title":"Prostate"},{"key":"10.1016\/j.molcel.2026.06.003_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-05078-8","article-title":"p38-mediated phosphorylation at T367 induces EZH2 cytoplasmic localization to promote breast cancer metastasis","volume":"9","author":"Anwar","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molcel.2026.06.003_bib47","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10549-012-2055-z","article-title":"Invasive breast carcinomas in Ghana: high frequency of high grade, basal-like histology and high EZH2 expression","volume":"135","author":"Pang","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.molcel.2026.06.003_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-26993-3","article-title":"Inhibition of cytoplasmic EZH2 induces antitumor activity through stabilization of the DLC1 tumor suppressor protein","volume":"12","author":"Tripathi","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molcel.2026.06.003_bib49","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/jnc.14152","article-title":"Telomerase reverse transcriptase (TERT) - enhancer of zeste homolog 2 (EZH2) network regulates lipid metabolism and DNA damage responses in glioblastoma","volume":"143","author":"Ahmad","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molcel.2026.06.003_bib50","doi-asserted-by":"crossref","first-page":"8577","DOI":"10.1074\/jbc.RA118.006871","article-title":"Enhancer of zeste homolog 2 (EZH2) regulates adipocyte lipid metabolism independent of adipogenic differentiation: Role of apolipoprotein E","volume":"294","author":"Yiew","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molcel.2026.06.003_bib51","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/s41388-023-02631-8","article-title":"UHRF1\/UBE2L6\/UBR4-mediated ubiquitination regulates EZH2 abundance and thereby melanocytic differentiation phenotypes in melanoma","volume":"42","author":"Kuser-Abali","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.molcel.2026.06.003_bib52","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1073\/pnas.1308953111","article-title":"EZH2 expands breast stem cells through activation of NOTCH1 signaling","volume":"111","author":"Gonzalez","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.molcel.2026.06.003_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11091346","article-title":"Anti-Tumor Potential of IMP Dehydrogenase Inhibitors: A Century-Long Story","volume":"11","author":"Naffouje","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.molcel.2026.06.003_bib54","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.biocel.2007.12.018","article-title":"Characterisation of inosine monophosphate dehydrogenase expression during retinal development: differences between variants and isoforms","volume":"40","author":"Gunter","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.molcel.2026.06.003_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173580","article-title":"Therapeutic potential and molecular mechanisms of mycophenolic acid as an anticancer agent","volume":"887","author":"Benjanuwattra","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.molcel.2026.06.003_bib56","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1021\/cr990097b","article-title":"Mycophenolic Acid: a one hundred year odyssey from antibiotic to immunosuppressant","volume":"100","author":"Bentley","year":"2000","journal-title":"Chem. Rev."},{"key":"10.1016\/j.molcel.2026.06.003_bib57","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.cmet.2018.06.005","article-title":"Inosine Monophosphate Dehydrogenase Dependence in a Subset of Small Cell Lung Cancers","volume":"28","author":"Huang","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.molcel.2026.06.003_bib58","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1146\/annurev.pharmtox.010909.105844","article-title":"The RNA polymerase I transcription machinery: an emerging target for the treatment of cancer","volume":"50","author":"Drygin","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.molcel.2026.06.003_bib59","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00412-013-0430-0","article-title":"The nucleolus \u2013 guardian of cellular homeostasis and genome integrity","volume":"122","author":"Grummt","year":"2013","journal-title":"Chromosoma"},{"key":"10.1016\/j.molcel.2026.06.003_bib60","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc.2017.104","article-title":"Ribosome biogenesis in cancer: new players and therapeutic avenues","volume":"18","author":"Pelletier","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.molcel.2026.06.003_bib61","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0092-8674(76)90175-6","article-title":"Control of nucleolar RNA synthesis by the intracellular pool sizes of ATP and GTP","volume":"7","author":"Grummt","year":"1976","journal-title":"Cell"},{"key":"10.1016\/j.molcel.2026.06.003_bib62","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1080\/15257770802145132","article-title":"Guanine nucleotide depletion mediates translocation of nucleolar proteins, including RNA helicase A (DHX-9)","volume":"27","author":"Huang","year":"2008","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.molcel.2026.06.003_bib63","doi-asserted-by":"crossref","DOI":"10.4161\/sgtp.29019","article-title":"Rho GTPases modulate malignant transformation of tumor cells","volume":"5","author":"Orgaz","year":"2014","journal-title":"Small GTPases"},{"key":"10.1016\/j.molcel.2026.06.003_bib64","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0003-9861(55)90098-9","article-title":"Biosynthesis of nucleic acid purines. II. Role of hypoxanthine and xanthine compounds","volume":"58","author":"Abrams","year":"1955","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.molcel.2026.06.003_bib65","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0003-9861(55)90347-7","article-title":"Biosynthesis of nucleic acid purines. I. Formation of guanine from adenine compounds in bone marrow extracts","volume":"56","author":"Abrams","year":"1955","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.molcel.2026.06.003_bib66","first-page":"164","article-title":"The biogenesis of pentosenucleic acid pyrimidines in the Ehrlich ascites tumor","volume":"15","author":"Lagerkvist","year":"1955","journal-title":"Cancer Res."},{"key":"10.1016\/j.molcel.2026.06.003_bib67","doi-asserted-by":"crossref","first-page":"76423","DOI":"10.18632\/oncotarget.19462","article-title":"Expression of EZH2 in uveal melanomas patients and associations with prognosis","volume":"8","author":"Cheng","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.molcel.2026.06.003_bib68","doi-asserted-by":"crossref","first-page":"11606","DOI":"10.1073\/pnas.1933744100","article-title":"EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells","volume":"100","author":"Kleer","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.molcel.2026.06.003_bib69","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.1227604","article-title":"EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent","volume":"338","author":"Xu","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.molcel.2026.06.003_bib70","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1158\/1541-7786.MCR-10-0398","article-title":"Enhancer of zeste homolog 2 promotes the proliferation and invasion of epithelial ovarian cancer cells","volume":"8","author":"Li","year":"2010","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.molcel.2026.06.003_bib71","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nm.4098","article-title":"Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status","volume":"22","author":"Schoumacher","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.molcel.2026.06.003_bib72","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-020-01173-x","article-title":"Verification of EZH2 as a druggable target in metastatic uveal melanoma","volume":"19","author":"Jin","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.molcel.2026.06.003_bib73","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nchembio.1331","article-title":"Targeted disruption of the EZH2-EED complex inhibits EZH2-dependent cancer","volume":"9","author":"Kim","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.molcel.2026.06.003_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109410","article-title":"Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategy","volume":"36","author":"Terranova","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.molcel.2026.06.003_bib75","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1016\/j.cub.2015.09.054","article-title":"TGF-beta-Induced Transcription Sustains Amoeboid Melanoma Migration and Dissemination","volume":"25","author":"Cantelli","year":"2015","journal-title":"Curr. Biol."},{"key":"10.1016\/j.molcel.2026.06.003_bib76","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1038\/s43018-024-00847-5","article-title":"The pro-oncogenic noncanonical activity of a RAS\u2217GTP:RanGAP1 complex facilitates nuclear protein export","volume":"5","author":"Tripathi","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.molcel.2026.06.003_bib77","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0300-9084(02)01400-1","article-title":"Participation of yeast inosine 5\u2032-monophosphate dehydrogenase in an in vitro complex with a fragment of the C-rich telomeric strand","volume":"84","author":"Cornuel","year":"2002","journal-title":"Biochimie"},{"key":"10.1016\/j.molcel.2026.06.003_bib78","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1042\/bj20031585","article-title":"Inosine 5\u2032-monophosphate dehydrogenase binds nucleic acids in vitro and in vivo","volume":"379","author":"McLean","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.molcel.2026.06.003_bib79","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1042\/BJ20042051","article-title":"Autosomal dominant retinitis pigmentosa mutations in inosine 5\u2032-monophosphate dehydrogenase type I disrupt nucleic acid binding","volume":"390","author":"Mortimer","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.molcel.2026.06.003_bib80","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1167\/iovs.05-0868","article-title":"Spectrum and frequency of mutations in IMPDH1 associated with autosomal dominant retinitis pigmentosa and leber congenital amaurosis","volume":"47","author":"Bowne","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.molcel.2026.06.003_bib81","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.molcel.2012.04.030","article-title":"Metabolic enzyme IMPDH is also a transcription factor regulated by cellular state","volume":"47","author":"Kozhevnikova","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molcel.2026.06.003_bib82","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2174\/092986730607220401122851","article-title":"Consequences of IMP dehydrogenase inhibition, and its relationship to cancer and apoptosis","volume":"6","author":"Jayaram","year":"1999","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.molcel.2026.06.003_bib83","first-page":"3349","article-title":"Tiazofurin effects on IMP-dehydrogenase activity and expression in the leukemia cells of patients with CML blast crisis","volume":"16","author":"Wright","year":"1996","journal-title":"Anticancer Res."},{"key":"10.1016\/j.molcel.2026.06.003_bib84","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/223848a0","article-title":"Mycophenolic acid: an anti-cancer compound with unusual properties","volume":"223","author":"Carter","year":"1969","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2026.06.003_bib85","first-page":"1795","article-title":"Experimental antitumor activity and preclinical toxicology of mycophenolic acid","volume":"32","author":"Sweeney","year":"1972","journal-title":"Cancer Res."},{"key":"10.1016\/j.molcel.2026.06.003_bib86","doi-asserted-by":"crossref","first-page":"E407","DOI":"10.1111\/ctr.12164","article-title":"Effect of mycophenolate mofetil on hematological side effects incidence in renal transplant recipients","volume":"27","author":"Sobiak","year":"2013","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.molcel.2026.06.003_bib87","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00204-014-1247-1","article-title":"Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update","volume":"88","author":"Staatz","year":"2014","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.molcel.2026.06.003_bib88","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/01.tp.0000296854.68123.03","article-title":"Expression of IMPDH1 and IMPDH2 after transplantation and initiation of immunosuppression","volume":"85","author":"Bremer","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.molcel.2026.06.003_bib89","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1567-5769(02)00210-2","article-title":"Mycophenolic acid inhibits inosine 5\u2032-monophosphate dehydrogenase and suppresses immunoglobulin and cytokine production of B cells","volume":"3","author":"Jonsson","year":"2003","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.molcel.2026.06.003_bib90","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41586-024-08224-z","article-title":"Gliocidin is a nicotinamide-mimetic prodrug that targets glioblastoma","volume":"636","author":"Chen","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2026.06.003_bib91","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/162750","article-title":"Chemistry and biological activities of flavonoids: an overview","volume":"2013","author":"Kumar","year":"2013","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.molcel.2026.06.003_bib92","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/pcmr.12097","article-title":"The Ludwig institute for cancer research Melbourne melanoma cell line panel","volume":"26","author":"Behren","year":"2013","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.molcel.2026.06.003_bib93","article-title":"Prospective isolation according to melanin pigment content of melanoma cells with heterogeneous potentials for disease propagation","volume":"4","author":"Fedele","year":"2025","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.molcel.2026.06.003_bib94","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/19491034.2019.1618175","article-title":"Identification of new transmembrane proteins concentrated at the nuclear envelope using organellar proteomics of mesenchymal cells","volume":"10","author":"Cheng","year":"2019","journal-title":"Nucleus"},{"key":"10.1016\/j.molcel.2026.06.003_bib95","doi-asserted-by":"crossref","unstructured":"Stewart, S.A., Dykxhoorn, D.M., Palliser, D., Mizuno, H., Yu, E.Y., An, D.S., Sabatini, D.M., Chen, I.S., Hahn, W.C., Sharp, P.A., et al. (2003). Lentivirus-delivered stable gene silencing by RNAi in primary cells. 9, 493\u2013501.","DOI":"10.1261\/rna.2192803"},{"key":"10.1016\/j.molcel.2026.06.003_bib96","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms9126","article-title":"YAP1 and AR interactions contribute to the switch from androgen-dependent to castration-resistant growth in prostate cancer","volume":"6","author":"Kuser-Abali","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molcel.2026.06.003_bib97","doi-asserted-by":"crossref","first-page":"9236","DOI":"10.1093\/nar\/gku540","article-title":"A dimeric state for PRC2","volume":"42","author":"Davidovich","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molcel.2026.06.003_bib98","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.molcel.2026.06.003_bib99","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.molcel.2026.06.003_bib100","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.molcel.2026.06.003_bib101","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.molcel.2026.06.003_bib102","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1038\/nprot.2016.136","article-title":"The MaxQuant computational platform for mass spectrometry-based shotgun proteomics","volume":"11","author":"Tyanova","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.molcel.2026.06.003_bib103","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1021\/pr101065j","article-title":"Andromeda: a peptide search engine integrated into the MaxQuant environment","volume":"10","author":"Cox","year":"2011","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.molcel.2026.06.003_bib104","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nmeth.3901","article-title":"The Perseus computational platform for comprehensive analysis of (prote)omics data","volume":"13","author":"Tyanova","year":"2016","journal-title":"Nat. Methods"},{"key":"10.1016\/j.molcel.2026.06.003_bib105","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1021\/acs.jproteome.9b00496","article-title":"LFQ-Analyst: An Easy-To-Use Interactive Web Platform To Analyze and Visualize Label-Free Proteomics Data Preprocessed with MaxQuant","volume":"19","author":"Shah","year":"2020","journal-title":"J. Proteome Res."}],"container-title":["Molecular Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097276526003746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097276526003746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:55:04Z","timestamp":1785891304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1097276526003746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":105,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1097276526003746"],"URL":"https:\/\/doi.org\/10.1016\/j.molcel.2026.06.003","relation":{},"ISSN":["1097-2765"],"issn-type":[{"value":"1097-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytosolic EZH2-IMPDH2 complexes regulate melanoma progression and metastasis via GTP","name":"articletitle","label":"Article Title"},{"value":"Molecular Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molcel.2026.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}